2015 Annual Report Page Header

The Business Advisory Board is composed of leaders in the life-sciences and finance world with experience in the pharmaceutical, biotechnology, medical device, investment banking, venture capital and financial management industries. The BAB members assess grant and investment opportunities and provide advice and direction to support the commercialization of new therapies. The BAB members also work with the SAB and the Board in setting strategic direction to guide the organization and our programs.


  • Stephen D. Collins MD, PhD
    President, CEO & Director
    Insero Health, Inc.
  • Garry E. Menzel PhD, MBA
    Chief Business and Strategy Officer
    Pronutria Biosciences


  • Karen L. Bergman
    Founder and Principal
    BCC Partners
  • Thomas A. Bologna
    President & CEO
    Orchid Cellmark, Inc.
  • Frank Fischer
    President & CEO
    NeuroPace, Inc.
  • Jeffrey D. Glidden
    Executive Vice President & CFO
    Parametric Technology Corporation
  • Nina Graves PharmD
    Retired (Former) Epilepsy Program Director
    Medtronic Inc.
  • Warren Lammert
    Founder, Managing Partner
    Granite Point Capital
  • Lisa Lindahl
    Chief Executive Instigator at EZL Enterprises
    Co-founder and Partner at Bellisse
  • Heath Lukatch PhD
    Novo Ventures
  • Daniel J. O'Connell
    NeuroVentures Capital LLC
  • Sherrie Perkins
    Senior Director New Business Development
    Cyberonics, Inc.
  • David A. Sadock
    President & CEO
    Ethos Health Communications
  • Aaron Sandoski
    Managing Director
    Norwich Ventures
  • Nancy Santilli BSN, MSN
    Vice President, Commercial Strategy and Portfolio Planning
    Endo Pharmaceuticals, Inc.
  • Ned Scheetz
    Managing Director
    Aphelion Capital, LLC
  • Randy Siegel
    President, Local Digital Strategy
    Advance Publications, Inc.
  • Lauren Silverman PhD 
    Managing Director
    Novartis Option Fund
  • Matthew Simonian
    Senior Director, Epilepsy Marketing
    Cyberonics, Inc.
  • Reese S. Terry, Jr.
    Cyberonics, Inc.
  • Elizabeth S. Weiswasser
    Litigation Partner
    Weil, Gotshal & Manges LLP
  • Gregory T. Went PhD
    CEO and Chairman
    Adamas Pharmaceuticals, Inc.

NEXT: Scientific Advisory Board